Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma

NCT06302699 · clinicaltrials.gov ↗
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators